HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)

The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa.
Also Known As:
Immunoglobulin Heavy Chain; Heavy Chain, Immunoglobulin; Heavy-Chain Immunoglobulins; Ig Heavy Chains; Immunoglobulin Heavy Chain Subgroup VH-I; Immunoglobulin Heavy Chain Subgroup VH-III; Heavy Chain Immunoglobulins; Heavy Chains, Ig; Heavy Chains, Immunoglobulin; Immunoglobulin Heavy Chain Subgroup VH I; Immunoglobulin Heavy Chain Subgroup VH III; Immunoglobulins, Heavy Chain; Immunoglobulins, Heavy-Chain
Networked: 1667 relevant articles (23 outcomes, 112 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Yoshino, Tadashi: 12 articles (09/2021 - 09/2004)
2. Nakamura, Naoya: 12 articles (09/2018 - 06/2002)
3. Keating, Michael J: 12 articles (01/2018 - 06/2003)
4. Medeiros, L Jeffrey: 12 articles (04/2013 - 04/2002)
5. Neri, Antonino: 10 articles (01/2020 - 02/2005)
6. Xu, Wei: 10 articles (01/2020 - 07/2009)
7. Fan, Lei: 9 articles (01/2020 - 07/2009)
8. Gribben, John G: 9 articles (01/2015 - 07/2002)
9. Wierda, William G: 9 articles (08/2014 - 06/2003)
10. Gattei, Valter: 8 articles (01/2022 - 09/2004)

Related Diseases

1. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
2. Residual Neoplasm
05/01/2014 - "In the case of long-term remission (≥5 years; n = 8), peripheral blood was tested for minimal residual disease (MRD) by t(11; 14) polymerase chain reaction (PCR) and immunoglobulin heavy-chain (IGH) PCR at the last follow-up. "
01/01/2020 - "Test trial of spike-in immunoglobulin heavy-chain (IGH) controls for next generation sequencing quantification of minimal residual disease in acute lymphoblastic leukaemia."
06/01/2014 - "In this study, we compared immunoglobulin heavy-chain-gene-based minimal residual disease (MRD) detection by real-time quantitative PCR (RQ-PCR) and next-generation sequencing (NGS) to assess whether NGS could overcome some limitations of RQ-PCR and further increase sensitivity, specificity, accuracy and reproducibility. "
04/01/2013 - "In this study we aimed to assess the value of real-time polymerase chain reaction (RT-PCR) for detecting the immunoglobulin heavy chain (IgH) gene rearrangement using allele-specific molecular beacons as fluorescence probes to quantify minimal residual disease (MRD) and also to correlate post-treatment flow cytometric detection of plasma cells' (PCs) expression of CD19, CD38, CD45, CD56 and CD138 in MM. After diagnosis of 17 MM patients, the CDR1, CDR2 and CDR3 regions of the IgH gene were analysed and sequenced to identify IgH's clonal nature. "
04/01/2021 - "This review of laboratory testing in CLL focuses on emerging technologies for prognostication including single nucleotide polymorphism microarray for karyotypic analysis, targeted next generation sequencing analysis of the immunoglobulin heavy chain variable region gene as well as genes recurrently mutated in the disease such as TP53, and detection of minimal residual disease."
3. Neoplasms (Cancer)
4. B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
5. B-Cell Lymphoma (Lymphoma, B Cell)

Related Drugs and Biologics

1. DNA (Deoxyribonucleic Acid)
2. T-Cell Antigen Receptors (T-Cell Receptor)
3. Complementarity Determining Regions (Complementarity Determining Region)
4. Messenger RNA (mRNA)
5. RNA (Ribonucleic Acid)
6. gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)
7. Monoclonal Antibodies
8. Oligonucleotides
9. Cytokines
10. Recombinant DNA (Recombinant DNA Research)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Stem Cell Transplantation
3. Induction Chemotherapy
4. Therapeutics
5. Aftercare (After-Treatment)